Obesity is more than just weight gain—it’s a serious health issue that increases the risk of life-threatening conditions such as diabetes, hypertension, dyslipidemia, and cardiovascular disease. In particular, the accumulation of visceral fat is a major cause of lifestyle-related illnesses and chronic inflammation, making early intervention crucial.
One of the most talked-about treatments in recent years is a once-weekly subcutaneous injection of a GLP-1 receptor agonist called “Wegovy.” Wegovy works by suppressing appetite and extending satiety, naturally supporting dietary restriction. On average, it can lead to a 15% reduction in body weight over the course of a year.
For individuals who have struggled with traditional dieting, Wegovy offers a scientifically proven, effective method. It also helps prevent obesity-related complications and is gaining attention as a manageable weight-loss solution under the supervision of medical professionals.

We only offer officially approved and certified products within Japan, so you can use them with confidence.